Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.
Kritz A, Crown JP, Motzer RJ, Reich LM, Heller G, Moore MP, Hamilton N, Yao TJ, Heelan RT, Schneider JG, et al. Kritz A, et al. Among authors: moore mp. Cancer. 1993 Apr 15;71(8):2515-21. doi: 10.1002/1097-0142(19930415)71:8<2515::aid-cncr2820710814>3.0.co;2-2. Cancer. 1993. PMID: 8095854 Clinical Trial.
Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells.
Crown J, Wassherheit C, Hakes T, Fennelly D, Reich L, Moore M, Schneider J, Curtin J, Rubin SC, Reichman B, et al. Crown J, et al. Among authors: moore m. J Natl Cancer Inst. 1992 Dec 16;84(24):1935-6. doi: 10.1093/jnci/84.24.1935. J Natl Cancer Inst. 1992. PMID: 1281238 Clinical Trial. No abstract available.
Inflammatory breast cancer.
Moore MP, Ihde JK, Crowe JP Jr, Hakes TP, Kinne DW. Moore MP, et al. Arch Surg. 1991 Mar;126(3):304-6. doi: 10.1001/archsurg.1991.01410270044008. Arch Surg. 1991. PMID: 1998471
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.
Holmes FA, O'Shaughnessy JA, Vukelja S, Jones SE, Shogan J, Savin M, Glaspy J, Moore M, Meza L, Wiznitzer I, Neumann TA, Hill LR, Liang BC. Holmes FA, et al. Among authors: moore m. J Clin Oncol. 2002 Feb 1;20(3):727-31. doi: 10.1200/JCO.2002.20.3.727. J Clin Oncol. 2002. PMID: 11821454 Clinical Trial.
Breast conservation therapy for invasive carcinoma of the breast.
Borgen PI, Heerdt AS, Moore MP, Petrek JA. Borgen PI, et al. Among authors: moore mp. Curr Probl Surg. 1995 Mar;32(3):191-248. doi: 10.1016/s0011-3840(05)80016-4. Curr Probl Surg. 1995. PMID: 7882704 Free article. Review. No abstract available.
Inflammatory breast carcinoma: mammographic findings.
Dershaw DD, Moore MP, Liberman L, Deutch BM. Dershaw DD, et al. Among authors: moore mp. Radiology. 1994 Mar;190(3):831-4. doi: 10.1148/radiology.190.3.8115635. Radiology. 1994. PMID: 8115635
7,342 results